Tower Research Capital LLC (TRC) - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$103,929
-23.8%
5,050
+74.0%
0.00%
-40.0%
Q2 2023$136,452
+104863.1%
2,902
-6.5%
0.01%
+25.0%
Q1 2023$130
+293.9%
3,103
+257.1%
0.00%
+300.0%
Q4 2022$33
-100.0%
869
-92.1%
0.00%
-85.7%
Q3 2022$432,000
-37.8%
11,019
-48.8%
0.01%
-56.2%
Q2 2022$695,000
+11.7%
21,532
+14.6%
0.02%
+166.7%
Q1 2022$622,000
+49.9%
18,794
+92.4%
0.01%
-14.3%
Q4 2021$415,000
+57.2%
9,768
+63.8%
0.01%0.0%
Q3 2021$264,000
+417.6%
5,963
+565.5%
0.01%
+600.0%
Q2 2021$51,000
-31.1%
896
-9.7%
0.00%0.0%
Q1 2021$74,000
-88.5%
992
-86.7%
0.00%
-95.0%
Q4 2020$646,000
+466.7%
7,469
+299.0%
0.02%
+1900.0%
Q3 2020$114,000
-32.1%
1,872
-53.8%
0.00%
-85.7%
Q2 2020$168,000
+7.0%
4,051
+85.7%
0.01%
-46.2%
Q4 2019$157,000
+137.9%
2,181
+364.0%
0.01%
+160.0%
Q3 2019$66,000
-40.5%
470
-22.7%
0.01%
-28.6%
Q2 2019$111,000
+593.8%
608
+424.1%
0.01%
+600.0%
Q3 2018$16,000
-82.4%
116
-80.1%
0.00%
-80.0%
Q2 2018$91,000
-73.5%
582
-89.5%
0.01%
-82.1%
Q3 2017$344,000
+11366.7%
5,525
+5212.5%
0.03%
Q2 2016$3,000
-97.3%
104
-96.0%
0.00%
-100.0%
Q3 2015$110,000
+54.9%
2,592
+167.2%
0.01%
+83.3%
Q2 2015$71,000
+1083.3%
970
+663.8%
0.01%
+500.0%
Q1 2015$6,0001270.00%
Q4 2014$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q3 2014$8,0002520.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders